New study demonstrates utility of RiiQ™

A major publication by Dr Ann Falsey and the Janssen Research & Development team provides evidence to support the use of PROs (i.e., the RiiQ™) correlating with clinician assessments to gauge patient well-being and aid patient management by accurately assessing respiratory illness severity due to RSV, hMPV, or influenza.

Falsey A et al., Assessment of Illness Severity in Adults Hospitalized With Acute Respiratory Tract Infection due to Influenza, Respiratory Syncytial Virus, or Human Metapneumovirus. Influenza and Other Respiratory Viruses. 2024; 18:e13275